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Summary
While cellular responses to low oxygen (O2) or hypoxia have been studied extensively, the precise identity of mammalian
cellular O2 sensors remains controversial. Using murine embryonic cells lacking cytochrome c, and therefore mitochon-
drial activity, we show that mitochondrial reactive oxygen species (mtROS) are essential for proper O2 sensing and subse-
quent HIF-1α and HIF-2α stabilization at 1.5% O2. In the absence of this signal, HIF-α subunits continue to be degraded.
Furthermore, exogenous treatment with H2O2 or severe O2 deprivation is sufficient to stabilize HIF-α even in the absence
of cytochrome c and functional mitochondria. These results provide genetic evidence indicating that mtROS act upstream
of prolyl hydroxylases in regulating HIF-1α and HIF-2α in this O2-sensing pathway.Introduction
When confronted with a decrease in O2 levels, cells initiate a
myriad of responses to combat the imposing stress. Many hyp-
oxic transcriptional responses are mediated by the hypoxia in-
ducible factors (HIFs) whose activity is regulated mainly
through the stability of their α subunits, which are hydroxylated
on prolines within their oxygen-dependent degradation do-
mains (ODDs) under normoxic conditions (Ivan et al., 2001;
Jaakkola et al., 2001; Yu et al., 2001). The von Hippel-Lindau
tumor suppressor (pVHL) recognizes and targets hydroxylated
HIF-α for degradation via the 26S proteosome. Hypoxia inhib-
its hydroxylation and stabilized HIF-α translocates to the nu-
cleus, dimerizes with a HIF-β subunit (ARNT) and activates
transcription (Bruick, 2003; Wenger, 2002). Because of their O2
dependence (McNeill et al., 2002) and relatively high Km for O2
in vitro (Hirsila et al., 2003), it has been proposed that the HIF-
specific hydroxylases may directly sense O2 deprivation to sta-
bilize HIF.
Mitochondria have also been implicated in multiple HIF-de-
pendent and -independent hypoxic responses through the
hypoxic production of intracellular mtROS. These hypoxic
mtROS potentially regulate many cellular processes including
HIF-1α stability and transcriptional activity (Agani et al., 2000;
Agani et al., 2002b; Chandel et al., 1998; Chandel et al., 2000;
Sanjuan-Pla et al., 2005; Schroedl et al., 2002), myocyte con-
traction (Duranteau et al., 1998; Waypa et al., 2002), p38 acti-
vation (Kulisz et al., 2002), IL-6 production (Pearlstein et al.,
2002), glutathione depletion (Mansfield et al., 2004), Na,K-
ATPase activity (Dada et al., 2003), adipocyte differentiation
(Carriere et al., 2004), and anoxia-regulated gene expression in
yeast (Dirmeier et al., 2002). Furthermore, decreasing mtROS
levels with mitochondrial inhibitors or ROS scavengers pre-
vents these responses, indicating mtROS are necessary forCELL METABOLISM : JUNE 2005 · VOL. 1 · COPYRIGHT © 2005 ELSEVhypoxic events. Increases in ROS generation during normoxia
can also trigger hypoxic responses, including HIF-1α stabiliza-
tion (BelAiba et al., 2004; Chandel et al., 2000; Goyal et al.,
2004), suggesting that mtROS are sufficient to mimic hypoxia.
Despite this evidence, the mitochondria’s role in mammalian
cellular O2 sensing has remained controversial, particularly be-
cause the use of pharmacological agents to affect hypoxic HIF-
1α stabilization has produced conflicting data (Agani et al.,
2000; Agani et al., 2002a; Chandel et al., 1998; Chandel et al.,
2000; versus Enomoto et al., 2002; Srinivas et al., 2001; Vaux
et al., 2001). We investigated the controversy surrounding the
use of pharmacological agents by extending previous observa-
tions. Our results with mitochondria-deficient rho zero (ρ0) cells
and mitochondrial inhibitors support a role for mitochondria in
cellular O2 sensing. Furthermore, using cytochrome c null em-
bryonic cells, we clearly demonstrate that functional mito-
chondria are necessary to produce ROS and subsequently sta-
bilize HIF-1α or HIF-2α in response to hypoxia. This novel
genetic evidence indicates that mtROS act upstream of prolyl
hydroxylases in regulating the stability of both HIF-1α and HIF-
2α in mammalian cells.
Results
While mitochondria-deficient Hep3B and HEK293 ρ0 cells were
initially shown to be defective in hypoxic HIF-1α stabilization
(Chandel et al., 1998; Chandel et al., 2000), later work sug-
gested this may be an artifact due to selection with rotenone
(Vaux et al., 2001) or mutation of nuclear genes. We chose to
address this discrepancy by generating ρ0 cells (King and At-
tardi, 1996) and avoiding selection with mitochondrial inhibi-
tors. To minimize the impact of random mutation of nuclear
genes, fresh pools of cells were generated for each experi-
ment. We monitored ρ0 status via mtDNA content by semiquan-IER INC. DOI 10.1016/j.cmet.2005.05.003 393
S H O R T A R T I C L Etitative PCR of the mitochondrially encoded genes, cytochrome
oxidase subunit II (COXII), NADH dehydrogenase subunits I and
II (ND1/2), and cytochrome b (CYTB), and complex IV function
via respirometry.
Hep3B cells required treatment with 100 ng/ml ethidium bro-
mide (EtBr) for 3 weeks to disrupt mtDNA replication, resulting
in loss of mtDNA (Figure 1A and see Figure S1A in the Supple-
mental Data available with this article online) and inhibition of
respiration (data not shown), compared to cells treated with 0
or 50 ng/ml EtBr. Upon exposure to hypoxia (1.5% O2), control
cells treated with 0 or 50 ng/ml EtBr stabilized HIF-1α and HIF-
2α while the ρ0 cells exhibited an attenuated response. These
cells retained HIF expression as treatment with the hypoxia mi-
metic desferroxamine (DFX) stabilized HIF-α similarly in all
three populations of cells (Figure 1A). To ensure this was not a
difference in cell type or severity of EtBr treatment, we also
generated HEK293 ρ0 cells similar to those of Chandel et al.
(2000). Treatment of HEK293 cells with 50 ng/ml EtBr for 2
weeks depleted mtDNA and decreased cellular respiration by
95% (Figures 1B and S1A). When subjected to hypoxia, control
cells stabilized both HIF-α subunits while the ρ0 cells failed to
stabilize either HIF-α protein while responding equally well to
DFX (Figure 1B). Similar results were obtained with HEK293T
cells (Figure S1B).
It has been hypothesized that observed differences in ρ0Figure 1. Functional mitochondria are required for hypoxic HIF-α stabilization
A) Hep3B cells treated with 0, 50, or 100 ng/ml EtBr for 3 weeks and mtDNA levels determined via COXII PCR. Hep3B control (0 and 50) or ρ0 (100) cells exposed to
4 hr of normoxia (21% O2), hypoxia (1.5% O2), or DFX (100 M) and analyzed for HIF-1α and HIF-2α via Western blot with γ-glutamylcysteine synthetase (GCS) as a
loading control.
B) HEK293 cells treated for 2 weeks with 0 or 50 ng/ml EtBr analyzed for COXII mtDNA and respiration (Resp, expressed as nmol O2 consumed/ml/min/106 cells).
Control (0) or ρ0 (50) cells exposed to 4 hr of normoxia, hypoxia, or DFX.
C) 143B and 206ρ0 cells analyzed for COXII mtDNA and respiration. Cells exposed to normoxia (N), hypoxia (H), hypoxia plus 100 ng/ml myxothiazol (M), or DFX (D)
for 4 hr.
D and E) Hep3B cells treated with rotenone (D) or myxothiazol (E) and exposed to hypoxia or 100 M CoCl2 for 4 hr. HIF-1α and HIF-2α levels determined and
respiration measured to confirm mitochondrial inhibition.394hypoxic responses may arise through the use of freshly gener-
ated ρ0 populations versus established cell lines that may have
undergone metabolic adaptation or mutations in nuclear genes
(Vaux et al., 2001). To address this concern, we obtained the
human osteosarcoma-derived 143B parental cell line and
143B-206ρ0 derivative used in previous studies (Srinivas et al.,
2001; Vaux et al., 2001). ρ0 status was confirmed by lack of
mtDNA and respiration (Figures 1C and S1A). In contrast to
these previous reports which used more severe hypoxia
(0.5%–0.1% O2), 143B-206ρ0 cells failed to stabilize HIF-α
when exposed to 1.5% O2 for 4 hr but responded to DFX.
These findings indicate that mitochondrial electron transport
is required for hypoxic HIF-α stabilization at 1.5%, supporting
previous observations (Chandel et al., 1998; Chandel et al.,
2000) and suggesting that differences in O2 tension may ex-
plain the discrepant results (see Discussion).
Due to concerns about long-term metabolic adaptation or
genetic alteration of ρ0 cells, we investigated the effect of acute
mitochondrial inhibition by the complex I inhibitor rotenone or
the complex III inhibitor myxothiazol, minimizing nonspecific
effects by employing nanomolar doses. We expanded on prior
experiments by using wider dose ranges, ensuring the treat-
ments inhibited mitochondrial function for the duration of the
experiment and controlling for nonspecific effects on HIF-α
levels. Treatment of Hep3B cells with rotenone (Figure 1D) orCELL METABOLISM : JUNE 2005
Cytochrome c is required for HIF-α activationmyxothiazol (Figure 1E) for 4 hr inhibited respiration and pre-
vented hypoxic HIF-1α and HIF-2α stabilization, further sup-
porting a role for mitochondria in this process. Of note, the
highest doses of myxothiazol also affected HIF-α stabilization
in response to CoCl2 (Figure 1E), highlighting the difficulties
inherent to drug treatments that have prevented widespread
acceptance of the mitochondrial O2 sensing model.
Therefore, we employed a genetic model to investigate the
role of mitochondrial function in cellular O2 sensing, avoiding
the nonspecific effects of pharmacological inhibition. Targeted
mutagenesis of the murine somatic cytochrome c gene (Cyt c)
has previously been described (Li et al., 2000). Loss of cyto-
chrome c prevents oxidation of cytochrome c1, keeping the
Rieske iron-sulfur protein reduced. This prevents oxidation of
ubiquinol and formation of the ubisemiquinone radical, thus
eliminating one important source of superoxide implicated in
hypoxic HIF-1α stabilization (Chandel et al., 1998; Chandel et
al., 2000). Although this mutation results in embryonic death
by day 10.5, we generated wild-type (wt), heterozygous (Het),
and null cell lines from a representative litter of day 8.5 em-
bryos (Figure 2A). Wild-type and Het lines exhibited similar res-
piratory rates, while null cells were devoid of any measurable
mitochondrial O2 consumption (Figure 2C), or cytochrome c
protein (Figure 2B).
We first investigated real-time, in vivo ROS production in
these cell lines through the use of the oxidant-sensitive dye
dichlorodihydrofluorescein (DCFH; Figure 2D), and an ROS-
sensitive FRET probe (HSP-FRET; data not shown) utilizing sin-
gle-cell epifluorescence microscopy. Whereas both cell lines
exhibited similar basal levels of ROS production, wt cells dra-
matically increased DCFH oxidation upon exposure to hypoxia
while cytochrome c null cells exhibited an attenuated response
(Figure 2D). Importantly, treatment of the null cells with com-
plex III inhibitors myxothiazol or stigmatellin elicited no changeFigure 2. Cytochrome c null embryonic cells are de-
ficient in their hypoxic response
A) Genotype of individual cell lines determined via
PCR.
B) Cytochrome c protein expression determined via
Western blot.
C)Mitochondrial respiration was measured (± SEM).
D) Embryonic cells mounted in a flow-through
chamber and ROS production in response to 1% O2
was monitored with DCFH-DA. mtROS levels deter-
mined by treatment with 100 ng/ml myxothiazol.
E) Embryonic cells exposed to normoxia (N), hyp-
oxia (Hyp, 1.5% O2) or 100 M DFX for 4 hr in the
presence or absence of 100 ng/ml myxothiazol and
HIF-α levels determined. Densitometry analysis of
HIF-1α levels in five separate experiments normal-
ized to normoxic controls (± SEM).CELL METABOLISM : JUNE 2005in ROS production, while wt cells treated with inhibitors de-
creased their hypoxic ROS production to that observed for null
cells (Figure 2D and data not shown). Furthermore, null cells
were unable to stabilize HIF-1α or HIF-2α in response to hyp-
oxia in direct contrast to the wt and Het cells (Figure 2E) but
retained response to DFX, with HIF-α subunits appearing as
multiple bands due to posttranslational modifications. Myxothi-
azol (Figure 2E) or rotenone (Figure S1C) abolished hypoxic but
not DFX-induced HIF-α stabilization in cytochrome c-express-
ing cells. This argues strongly that the increased ROS pro-
duced in the hypoxic wt cells are mitochondrial and supports
the hypothesis that mtROS generated by complex III are re-
sponsible for hypoxic HIF-α stabilization.
Stable reintroduction of cytochrome c into an independent
null cell line restored respiration (Figure 3A) and hypoxic
mtROS accumulation (Figure 3B) as measured by an in vitro
endpoint assay. This correlated with a restored ability to prop-
erly stabilize HIF-1α to levels similar to wt, in a mitochondria-
dependent manner, and in multiple clones (Figure 3C). These
results suggest that the inability of null cells to properly sense
O2 is due to mitochondrial dysfunction resulting from cyto-
chrome c loss.
All embryonic cell lines responded similarly to DFX, suggest-
ing that cytochrome c null cells maintain normal HIF-α tran-
scription, translation, and degradation. However, to test if they
continue to hydroxylate and degrade HIF-α under hypoxic con-
ditions, cytochrome c wt or null cells were treated with 1.5%
O2 in the presence of the proteosome inhibitor MG-132. While
the null cells failed to stabilize HIF-α in response to hypoxia,
inhibition of proteosome degradation by MG-132 led to HIF-α
accumulation similar to wt (Figure 4A). This demonstrates that
hydroxylation and degradation of HIF-α continued to occur in
the cytochrome c null cells even at this reduced O2 concen-
tration.395
S H O R T A R T I C L EFigure 3. Reintroduction of cytochrome c restores hypoxic response
A) An independent cytochrome c null cell line stably transfected with a control
(Hyg), or cytochrome c expression vector (CytC) and assayed for cytochrome c
protein levels and respiratory activity.
B) ROS accumulation monitored with carboxy-H2 DCFDA and fluorescence de-
termined (± SEM) after 4 hr of hypoxia.
C) Cells exposed to 4 hr of normoxia (N), 100 M DFX (D), or hypoxia in the
absence (H) or presence (M) of 100 ng/ml myxothiazol and HIF-1α expression de-
termined.hypoxia (Figure 4C). In addition, incubation of Hep3B cells with It was previously shown that HIF-1α stabilization is mito-
Figure 4. Proteosome inhibition, anoxia, or H2O2 is
sufficient to stabilize HIF-α in cytochrome c null
cells
A) Cytochrome c wt or null cells exposed to 4 hr of
normoxia or hypoxia in the presence of 10 M MG-
132 or 100 M DFX and HIF-α levels determined.
B) Embryonic cells exposed to 21%, 1.5%, and 0%
O2, or 100 M DFX for 3 hr.
C) Hep3B cells treated with H2O2 or exposed to
hypoxia (H) for 2 hr.
D) Hep3B cells treated with glucose oxidase en-
zyme (Gluc Ox) or CoCl2 for 2 hr in the presence or
absence of 100 units/ml catalase.
E) Cytochrome c null cells treated with boluses of
t-Butyl hydroperoxide (TBP) every 15 mins or a sin-
gle dose of CoCl2 (100 M) for 1 or 2 hr.The mitochondrial dependence of HIF-α stabilization can
also be bypassed by severe O2 deprivation (anoxia z 0% O2)
where prolyl hydroxylases appear to be substrate limited
(Schroedl et al., 2002). While the null cells failed to stabilize
HIF-1α or HIF-2α in response to 1.5% O2, exposure to 0% O2
induced both HIF-α subunits in a mitochondria-independent
manner (Figure 4B), suggesting functional mitochondria are not
necessary for cellular responses to severe O2 deprivation in
which the hydroxylases are directly inhibited.
To test whether ROS production is also sufficient to stabilize
HIF-1α, Hep3B cells were treated with exogenous hydrogen
peroxide (H2O2) as previously described (Chandel et al., 2000).
Doses as low as 25 M stabilized HIF-1α as well or better than396the H2O2-generating enzyme, glucose oxidase, was also suffi-
cient to stabilize HIF-1α and HIF-2α. This was an H2O2-depen-
dent event, as exogenous catalase abolished HIF-α stabiliza-
tion (Figure 4D). To ensure the effects of exogenous H2O2 were
not mediated by mitochondria, cytochrome c null cells were
treated with t-Butyl hydroperoxide (TBP), a stable H2O2 analog.
Even in the absence of functional mitochondria, exogenous
H2O2 induced HIF-1α and HIF-2α stabilization similar to the
hypoxia mimetic CoCl2 (Figure 4E). These results indicate that
ROS production is sufficient for HIF-α stabilization and func-
tions downstream of the mitochondria.
Discussion
Cytochrome c null cells provide novel genetic evidence sup-
porting a role for mtROS in the mammalian cellular O2 sensing
pathway, without the use of EtBr or pharmacological inhibitors.
Utilizing this genetic model of mitochondrial dysfunction, we
show that ROS production is necessary and sufficient to pro-
mote HIF-α stabilization, presumably acting through the prolyl
hydroxylases. While the null cells appear to produce some hyp-
oxic ROS, it is insufficient to stabilize HIF-α, suggesting that
either the cellular compartment(s) participating in redox signal-
ing, the type, or the magnitude of the ROS signal, is important.
It should also be noted that in contrast to studies in yeast
(Barros et al., 2003) and isolated mitochondria (Zhao and Xu,
2004), loss of cytochrome c did not lead to increased basal
levels of ROS production. Whether this is due to species differ-
ences or adaptation, the salient result is that null cells fail to
sufficiently increase mtROS production upon hypoxic expo-
sure, correlating with an inability to properly stabilize HIF-α.
While ROS are involved in the hypoxic response and can in-
duce HIF-α in a mitochondria-independent manner, other mito-
chondria-derived factors also clearly play a role in modulating
hydroxylase activity (Selak et al., 2005).CELL METABOLISM : JUNE 2005
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al., 2002), and we have confirmed those results with cyto-
chrome c null cells. This observation may explain some of the
apparent discrepancies in the literature regarding the use of ρ0
cells and pharmacological inhibitors. Indeed, we have clearly
shown (using ρ0 cells, mitochondrial inhibitors, and cyto-
chrome c null cells) that at 1.5% O2 the mitochondria play a
vital role in proper cellular O2 sensing, supporting previous ob-
servations (Agani et al., 2000; Agani et al., 2002b; Chandel et
al., 1998; Chandel et al., 2000; Schroedl et al., 2002). The
discrepancies arose when comparing these results to those
obtained under more severe hypoxic stress (Enomoto et al.,
2002; Srinivas et al., 2001; Vaux et al., 2001) in which it ap-
pears the hydroxylases are directly responsible for O2 sensing
and HIF-α stabilization. These results emphasize the need to
accurately define the levels of O2 and consider the effects of
various O2 tensions when investigating hypoxic phenomena.
It is possible that increased O2 availability in the respiratory-
deficient cytochrome c null cells accounts for differences in
sensitivity to hypoxia, similar to that recently reported with nit-
ric oxide-mediated (NO) mitochondrial inhibition (Hagen et al.,
2003). However, we have found that modulation of mitochon-
drial O2 consumption with the complex IV inhibitor KCN or the
mitochondrial uncoupler FCCP is insufficient to impact HIF-1α
stabilization in Hep3B or HEK293 cells (Figure S2). Further-
more, while intracellular O2 gradients have been shown to exist
near mitochondrial clusters, other organelles and the cyto-
plasm (where prolyl hydroxylases are reported to reside;
Metzen et al., 2003) have O2 levels similar to the surrounding
media which do not change upon mitochondrial inhibition
(Jones, 1986; Jones and Mason, 1978). Of note, a mitochon-
drially-targeted antioxidant has recently been shown to block
hypoxic mtROS production and HIF-1α stabilization without af-
fecting cellular respiration (Sanjuan-Pla et al., 2005). Taken to-
gether with our results, this suggests that upon mitochondrial
inhibition, it is the inability to produce mtROS from complex III
during hypoxia that results in the O2 sensing defect. Further-
more, we demonstrate that exogenous ROS can lead to the
stabilization of HIF-α even when O2 levels are high, providing
further proof that mtROS are important components of cellular
O2 sensing pathways.
How mtROS affect hydroxylase activity is critical to under-
standing cellular O2 sensing. ROS are known to be involved in
a number of signaling pathways (Thannickal and Fanburg,
2000) that potentially modulate hydroxylase activity. Alterna-
tively, ROS production could result in redox-mediated events
within the cell. Recently, redox changes through the depletion
of ascorbate by CoCl2 (Salnikow et al., 2004) or via oxidation
of cellular iron by persistent ROS production (Gerald et al.,
2004) have been shown to inhibit hydroxylase activity leading
to stabilization of HIF-α subunits.
Our genetic model in which the hypoxic response has been
altered such that cells retain functional prolyl hydroxylases but
lack the ability to properly sense and signal O2 deprivation pro-
vides a unique tool to investigate the in vivo regulation of the
prolyl hydroxylases. Indeed, our work suggests that in vitro
models (Hirsila et al., 2003; Ivan et al., 2001; Jaakkola et al.,
2001; Yu et al., 2001) may fail to fully recapitulate in vivo cellu-
lar O2 sensing, since in the absence of functional mitochondria,
hydroxylases appear to efficiently target HIF for degradation at
1.5% O intracellularly. It is likely that an array of mammalian2
CELL METABOLISM : JUNE 2005cellular O2 sensors exist, controlling various hypoxic responses
depending on the cell type, O2 tension, and other cellular con-
ditions. Through the use of cytochrome c null cells, we have
confirmed that mitochondria are essential for hypoxic HIF-1α
stabilization at 1.5% O2 and show the same is true for HIF-2α.
This, along with other emerging genetic models (Brunelle et al.,
2005 [this issue of Cell Metabolism]; Guzy et al., 2005 [this
issue of Cell Metabolism]), will provide valuable tools for inves-
tigating the role of the mitochondria in other hypoxic phe-
nomena.
Experimental procedures
Tissue-culture cells and reagents
Hep3B, HEK293, and 143B cell lines were maintained in Dulbecco’s Modi-
fied Eagle’s Medium (DMEM; CellGro), 10% fetal bovine serum (FBS; Gem-
Cell), 2 mM glutamine, 100 units/ml penicillin, 100 g/ml streptomycin, 0.1
mM MEM nonessential amino acids, and 1mM sodium pyruvate. Murine
embryonic cells were maintained in DMEM with 4.5 g glucose/ml, 20% FBS
(Hyclone), 25 mM HEPES, 2 mM glutamine, 100 units/ml penicillin, 100 g/
ml streptomycin, 0.1 mM MEM nonessential amino acids, 50 M β-mercap-
toethanol, 500–1000 units/ml mouse LIF, 2 mM sodium pyruvate, and 50
g/ml uridine.
Hypoxia and anoxia
Hypoxia (1.5% O2, 5% CO2, 93.5% N2) was achieved using an In Vivo2
hypoxic workstation (Ruskinn Technologies, Leeds, United Kingdom), with
all extracts prepared inside the workstation to prevent reoxygenation. An-
oxic experiments were carried out in Coy Laboratories glove box work-
stations equilibrated to either hypoxia (1.5% O2, 5% CO2, 93.5% N2) or
anoxia (5% CO2, 3%–4% H2, balance N2), with a palladium catalyst.
Rho zero (ρ0) generation
Cultures were treated with EtBr (50 or 100 ng/ml) in complete DMEM sup-
plemented with 0.1 mM MEM nonessential amino acids (Gibco), 2.5 mM
sodium pyruvate, and 50 g/ml uridine (King and Attardi, 1996). Cells were
considered ρ0 when there was no detectable mtDNA by PCR and no mito-
chondria-dependent O2 consumption. O2 consumption rate was measured
in a water-jacketed respirometer chamber by using an oxygen electrode
(Hansatech Instruments, Norfolk, England) at 37°C, subtracting out KCN-
resistance O2 consumption to calculate respiratory activity.
Western blots
Whole-cell lysates were prepared in 50 mM Tris (pH 7.4), 150 mM NaCl,
5 mM EDTA, 0.1% SDS, and complete protease inhibitor (Roche Molecular
Biochemicals). Antibodies used were: α-Human HIF-1α (Transduction
Laboratories), α-murine HIF-1α (Simon Laboratory), α-HIF-2α (Novus), α-cyto-
chrome c (BD PharMingen), and α-GCS heavy subunit (Neomarkers).
Mouse embryonic cells
Murine embryonic cells were generated as previously described (Li et al.,
2000). Briefly, day 8.5 embryos were dissected free of maternal tissues,
minced, and treated with 0.25% trypsin with EDTA (Gibco) for 5–15 min at
37°C. After trypsin inactivation with FBS, the cells were plated onto mitomy-
cin-C-treated mouse embryonic fibroblasts (MEFs) and after 2–3 weeks
adapted for growth on gelatin. Genotyping was performed as previously
described (Li et al., 2000). Cytochrome c expression was restored to the
null cells by electroporation with a full-length murine cDNA encoding the
somatic cytochrome c under the control of the EF-1α promoter and selec-
tion of stable clones with hygromycin, with the empty vector serving as
a control.
ROS measurements
For real-time ROS measurements, cells on glass coverslips were mounted
in a flowthrough chamber and perfused with 5 M DCFH-DA in a basic salt
solution bubbled with a 21% O2, 5% CO2, 74% N2 gas mixture. Hypoxia
was induced by bubbling with a 1% O2, 5% CO2, 96% N2 gas mixture.
Fluorescence was monitored with an inverted epifluorescence microscope.
For the endpoint assay, cells were incubated in PBS with 20 M 5- (and 6)-397
S H O R T A R T I C L Ecarboxy-2#, 7’- dichlorodihydrofluorescein diacetate (carboxy-H2DCFDA).
Cells were washed from the plate in the incubation medium and transferred
to an opaque 96-well plate, excited at 488 nm, and fluorescence emission
was measured at 530 nm using a Fluoromax-2 fluorimeter (Jobin Yvon
Spex, Edison, New Jersey). Hypoxic samples were harvested under hypoxic
conditions in the Ruskinn In Vivo2 workstation, and the plate was kept
sealed prior to reading.
Supplemental data
Supplemental Data include two figures and Supplemental Experimental Pro-
cedures and can be found with this article online at http://www.cellmetabolism.
org/cgi/content/full/1/6/393/DC1/.
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